BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1939 related articles for article (PubMed ID: 31127138)

  • 1. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
    Qiu J; Sun M; Wang Y; Chen B
    Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 4. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
    Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
    Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
    Alatan H; Chen Y; Zhou J; Wang L
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening the Biomarkers and Related Medicines for Gastric Adenocarcinoma.
    Lin J; Xu N; An W
    J Coll Physicians Surg Pak; 2024 Mar; 34(3):290-295. PubMed ID: 38462863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
    Yu-Jing T; Wen-Jing T; Biao T
    Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer.
    Xu J; Wang X; Ke Q; Liao K; Wan Y; Zhang K; Zhang G; Wang X
    Sci Rep; 2021 Jul; 11(1):15412. PubMed ID: 34326374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
    Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
    Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
    Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
    Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome sequencing identifies prognostic genes involved in gastric adenocarcinoma.
    Li M; Bai M; Wu Y; Yang S; Zheng L; Sun L; Yu C; Huang Y
    Mol Cell Biochem; 2023 Dec; 478(12):2891-2906. PubMed ID: 36944795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
    Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
    J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.